Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2008 1
2009 1
2013 1
2014 4
2015 4
2016 7
2017 12
2018 8
2019 8
2020 13
2021 17
2022 13
2023 10

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.
Fendler WP, Weber M, Iravani A, Hofman MS, Calais J, Czernin J, Ilhan H, Saad F, Small EJ, Smith MR, Perez PM, Hope TA, Rauscher I, Londhe A, Lopez-Gitlitz A, Cheng S, Maurer T, Herrmann K, Eiber M, Hadaschik B. Fendler WP, et al. Among authors: rauscher i. Clin Cancer Res. 2019 Dec 15;25(24):7448-7454. doi: 10.1158/1078-0432.CCR-19-1050. Epub 2019 Sep 11. Clin Cancer Res. 2019. PMID: 31511295
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study.
Gafita A, Rauscher I, Weber M, Hadaschik B, Wang H, Armstrong WR, Tauber R, Grogan TR, Czernin J, Rettig MB, Herrmann K, Calais J, Weber WA, Benz MR, Fendler WP, Eiber M. Gafita A, et al. Among authors: rauscher i. J Nucl Med. 2022 Nov;63(11):1651-1658. doi: 10.2967/jnumed.121.263072. Epub 2022 Apr 14. J Nucl Med. 2022. PMID: 35422442 Free PMC article.
PSMA Ligands for PET Imaging of Prostate Cancer.
Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, Afshar-Oromieh A, Herrmann K, Eiber M. Schwarzenboeck SM, et al. Among authors: rauscher i. J Nucl Med. 2017 Oct;58(10):1545-1552. doi: 10.2967/jnumed.117.191031. Epub 2017 Jul 7. J Nucl Med. 2017. PMID: 28687599 Free article. Review.
A Clinical Role of PET-MRI in Prostate Cancer ?
Gammel MCM, Solari EL, Eiber M, Rauscher I, Nekolla SG. Gammel MCM, et al. Among authors: rauscher i. Semin Nucl Med. 2023 Aug 29:S0001-2998(23)00069-7. doi: 10.1053/j.semnuclmed.2023.08.001. Online ahead of print. Semin Nucl Med. 2023. PMID: 37652782 Review.
Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer.
Feuerecker B, Chantadisai M, Allmann A, Tauber R, Allmann J, Steinhelfer L, Rauscher I, Wurzer A, Wester HJ, Weber WA, d'Alessandria C, Eiber M. Feuerecker B, et al. Among authors: rauscher i. J Nucl Med. 2022 Jun;63(6):833-839. doi: 10.2967/jnumed.121.262671. Epub 2021 Sep 16. J Nucl Med. 2022. PMID: 34531260 Free PMC article.
79 results